| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | sphingolipid delta-4 desaturase activity | 1.47e-05 | 2 | 77 | 2 | GO:0042284 | |
| GeneOntologyMolecularFunction | L-leucine binding | 3.04e-04 | 7 | 77 | 2 | GO:0070728 | |
| GeneOntologyMolecularFunction | ribonucleoside triphosphate phosphatase activity | 7.65e-04 | 775 | 77 | 10 | GO:0017111 | |
| GeneOntologyMolecularFunction | oxidoreductase activity, acting on paired donors, with oxidation of a pair of donors resulting in the reduction of molecular oxygen to two molecules of water | 1.11e-03 | 13 | 77 | 2 | GO:0016717 | |
| GeneOntologyMolecularFunction | pyrophosphatase activity | 1.39e-03 | 839 | 77 | 10 | GO:0016462 | |
| GeneOntologyMolecularFunction | hydrolase activity, acting on acid anhydrides | 1.41e-03 | 840 | 77 | 10 | GO:0016817 | |
| GeneOntologyMolecularFunction | hydrolase activity, acting on acid anhydrides, in phosphorus-containing anhydrides | 1.41e-03 | 840 | 77 | 10 | GO:0016818 | |
| GeneOntologyMolecularFunction | ATP hydrolysis activity | 1.55e-03 | 441 | 77 | 7 | GO:0016887 | |
| GeneOntologyMolecularFunction | protein kinase activator activity | 2.64e-03 | 149 | 77 | 4 | GO:0030295 | |
| GeneOntologyMolecularFunction | amino acid binding | 2.82e-03 | 73 | 77 | 3 | GO:0016597 | |
| GeneOntologyMolecularFunction | helicase activity | 3.26e-03 | 158 | 77 | 4 | GO:0004386 | |
| GeneOntologyMolecularFunction | kinase activator activity | 3.34e-03 | 159 | 77 | 4 | GO:0019209 | |
| GeneOntologyMolecularFunction | RNA helicase activity | 3.41e-03 | 78 | 77 | 3 | GO:0003724 | |
| GeneOntologyMolecularFunction | ATP-dependent activity, acting on RNA | 3.66e-03 | 80 | 77 | 3 | GO:0008186 | |
| GeneOntologyMolecularFunction | enzyme activator activity | 3.73e-03 | 656 | 77 | 8 | GO:0008047 | |
| GeneOntologyCellularComponent | acrosomal matrix | 1.33e-04 | 5 | 77 | 2 | GO:0043159 | |
| Domain | DES1/DES2 | 1.68e-05 | 2 | 77 | 2 | IPR011388 | |
| Domain | Lipid_DES | 1.68e-05 | 2 | 77 | 2 | PF08557 | |
| Domain | Sphingolipid_d4-desaturase_N | 1.68e-05 | 2 | 77 | 2 | IPR013866 | |
| Domain | Lipid_DES | 1.68e-05 | 2 | 77 | 2 | SM01269 | |
| Domain | Mob1_phocein | 3.48e-04 | 7 | 77 | 2 | PF03637 | |
| Domain | MOB_kinase_act_fam | 3.48e-04 | 7 | 77 | 2 | IPR005301 | |
| Domain | - | 3.48e-04 | 7 | 77 | 2 | 1.20.140.30 | |
| Domain | Mob1_phocein | 3.48e-04 | 7 | 77 | 2 | SM01388 | |
| Domain | FA_desaturase_dom | 4.62e-04 | 8 | 77 | 2 | IPR005804 | |
| Domain | FA_desaturase | 4.62e-04 | 8 | 77 | 2 | PF00487 | |
| Domain | Pyridoxal_deC | 4.62e-04 | 8 | 77 | 2 | PF00282 | |
| Domain | DDC_GAD_HDC_YDC | 4.62e-04 | 8 | 77 | 2 | PS00392 | |
| Domain | PyrdxlP-dep_de-COase | 4.62e-04 | 8 | 77 | 2 | IPR002129 | |
| Domain | A2M_N_2 | 4.62e-04 | 8 | 77 | 2 | SM01359 | |
| Domain | - | 4.62e-04 | 8 | 77 | 2 | 2.60.40.690 | |
| Domain | A2M_recep | 4.62e-04 | 8 | 77 | 2 | SM01361 | |
| Domain | A2M | 4.62e-04 | 8 | 77 | 2 | SM01360 | |
| Domain | A2M_N | 7.39e-04 | 10 | 77 | 2 | PF01835 | |
| Domain | A2M_N | 7.39e-04 | 10 | 77 | 2 | IPR002890 | |
| Domain | A-macroglobulin_rcpt-bd | 7.39e-04 | 10 | 77 | 2 | IPR009048 | |
| Domain | ALPHA_2_MACROGLOBULIN | 7.39e-04 | 10 | 77 | 2 | PS00477 | |
| Domain | A2M | 7.39e-04 | 10 | 77 | 2 | PF00207 | |
| Domain | A2M_N_2 | 7.39e-04 | 10 | 77 | 2 | IPR011625 | |
| Domain | A2M_comp | 7.39e-04 | 10 | 77 | 2 | IPR011626 | |
| Domain | A2M_N_2 | 7.39e-04 | 10 | 77 | 2 | PF07703 | |
| Domain | A2M_recep | 7.39e-04 | 10 | 77 | 2 | PF07677 | |
| Domain | A2M_comp | 7.39e-04 | 10 | 77 | 2 | PF07678 | |
| Domain | Macroglobln_a2 | 7.39e-04 | 10 | 77 | 2 | IPR001599 | |
| Domain | - | 1.08e-03 | 12 | 77 | 2 | 1.50.10.20 | |
| Domain | Ferritin-like_SF | 1.48e-03 | 14 | 77 | 2 | IPR009078 | |
| Domain | MAM_1 | 1.94e-03 | 16 | 77 | 2 | PS00740 | |
| Domain | MAM | 2.19e-03 | 17 | 77 | 2 | SM00137 | |
| Domain | MAM | 2.46e-03 | 18 | 77 | 2 | PF00629 | |
| Domain | MAM_dom | 2.46e-03 | 18 | 77 | 2 | IPR000998 | |
| Domain | MAM_2 | 2.46e-03 | 18 | 77 | 2 | PS50060 | |
| Domain | Terpenoid_cyclase/PrenylTrfase | 2.46e-03 | 18 | 77 | 2 | IPR008930 | |
| Domain | DEAD/DEAH_box_helicase_dom | 3.41e-03 | 73 | 77 | 3 | IPR011545 | |
| Domain | DEAD | 3.41e-03 | 73 | 77 | 3 | PF00270 | |
| Domain | NTR | 4.01e-03 | 23 | 77 | 2 | PS50189 | |
| Domain | Netrin_domain | 4.01e-03 | 23 | 77 | 2 | IPR001134 | |
| Domain | TIMP-like_OB-fold | 5.11e-03 | 26 | 77 | 2 | IPR008993 | |
| Domain | ArfGap | 6.34e-03 | 29 | 77 | 2 | SM00105 | |
| Domain | ArfGap | 6.34e-03 | 29 | 77 | 2 | PF01412 | |
| Domain | ARFGAP | 6.34e-03 | 29 | 77 | 2 | PS50115 | |
| Domain | ArfGAP | 6.34e-03 | 29 | 77 | 2 | IPR001164 | |
| Pathway | WP_SPHINGOLIPID_METABOLISM_OVERVIEW | 8.60e-05 | 25 | 49 | 3 | MM15931 | |
| Pathway | WP_SPHINGOLIPID_METABOLISM_INTEGRATED_PATHWAY | 9.70e-05 | 26 | 49 | 3 | M39784 | |
| Pathway | WP_SPHINGOLIPID_METABOLISM_INTEGRATED_PATHWAY | 9.70e-05 | 26 | 49 | 3 | MM15892 | |
| Pathway | WP_SPHINGOLIPID_METABOLISM_OVERVIEW | 1.09e-04 | 27 | 49 | 3 | M39863 | |
| Pathway | KEGG_SPHINGOLIPID_METABOLISM | 3.30e-04 | 39 | 49 | 3 | M15955 | |
| Pubmed | Identification and characterization of a sphingolipid delta 4-desaturase family. | 4.97e-06 | 2 | 78 | 2 | 11937514 | |
| Pubmed | 4.97e-06 | 2 | 78 | 2 | 21914808 | ||
| Pubmed | 1.49e-05 | 3 | 78 | 2 | 9693046 | ||
| Pubmed | ISG15 Connects Autophagy and IFN-γ-Dependent Control of Toxoplasma gondii Infection in Human Cells. | 3.20e-05 | 268 | 78 | 6 | 33024031 | |
| Pubmed | ZFP750 affects the cutaneous barrier through regulating lipid metabolism. | 4.66e-05 | 31 | 78 | 3 | 37115925 | |
| Pubmed | 4.94e-05 | 5 | 78 | 2 | 18583960 | ||
| Pubmed | Phospho-proteomic analyses of B-Raf protein complexes reveal new regulatory principles. | 4.95e-05 | 89 | 78 | 4 | 27034005 | |
| Pubmed | 6.15e-05 | 601 | 78 | 8 | 33658012 | ||
| Pubmed | Chromosomal distribution of ribosomal protein genes in the mouse. | 7.40e-05 | 6 | 78 | 2 | 7237550 | |
| Pubmed | 7.98e-05 | 37 | 78 | 3 | 19266077 | ||
| Pubmed | 1.01e-04 | 205 | 78 | 5 | 20436479 | ||
| Pubmed | 1.04e-04 | 7 | 78 | 2 | 1577483 | ||
| Pubmed | 1.06e-04 | 650 | 78 | 8 | 38777146 | ||
| Pubmed | The TRIM9/TRIM67 neuronal interactome reveals novel activators of morphogenesis. | 1.35e-04 | 218 | 78 | 5 | 33378226 | |
| Pubmed | 1.38e-04 | 8 | 78 | 2 | 19739119 | ||
| Pubmed | 1.38e-04 | 8 | 78 | 2 | 19565500 | ||
| Pubmed | 1.38e-04 | 8 | 78 | 2 | 22694956 | ||
| Pubmed | GGAPs, a new family of bifunctional GTP-binding and GTPase-activating proteins. | 1.77e-04 | 9 | 78 | 2 | 12640130 | |
| Pubmed | 1.90e-04 | 708 | 78 | 8 | 39231216 | ||
| Pubmed | Characterization of an exchangeable gene trap using pU-17 carrying a stop codon-beta geo cassette. | 2.04e-04 | 536 | 78 | 7 | 15840001 | |
| Pubmed | 2.09e-04 | 538 | 78 | 7 | 10512203 | ||
| Pubmed | Proteomic profiling of VCP substrates links VCP to K6-linked ubiquitylation and c-Myc function. | UBR1 RPL30 COPA SGPL1 A2ML1 PTPN23 ABCF2 PRMT3 RHOT2 DDX60L RPL19 | 2.11e-04 | 1353 | 78 | 11 | 29467282 |
| Pubmed | AGAP1/AP-3-dependent endocytic recycling of M5 muscarinic receptors promotes dopamine release. | 2.21e-04 | 10 | 78 | 2 | 20664521 | |
| Pubmed | Genes to diseases (G2D) computational method to identify asthma candidate genes. | 2.21e-04 | 10 | 78 | 2 | 18682798 | |
| Pubmed | A tumor-associated autoantibody panel for the detection of non-small cell lung cancer. | 2.21e-04 | 10 | 78 | 2 | 36531074 | |
| Pubmed | 2.55e-04 | 136 | 78 | 4 | 21280222 | ||
| Pubmed | Tau interactome maps synaptic and mitochondrial processes associated with neurodegeneration. | 2.60e-04 | 558 | 78 | 7 | 35063084 | |
| Pubmed | AGAP1, a novel binding partner of nitric oxide-sensitive guanylyl cyclase. | 2.70e-04 | 11 | 78 | 2 | 15381706 | |
| Pubmed | The E3 ubiquitin ligase HECTD1 contributes to cell proliferation through an effect on mitosis. | 3.03e-04 | 759 | 78 | 8 | 35915203 | |
| Pubmed | Many sequence variants affecting diversity of adult human height. | 3.09e-04 | 143 | 78 | 4 | 18391951 | |
| Pubmed | Enhanced analysis of the mouse plasma proteome using cysteine-containing tryptic glycopeptides. | 3.22e-04 | 59 | 78 | 3 | 17330941 | |
| Pubmed | LukS-PV inhibits hepatocellular carcinoma cells migration by downregulating HDAC6 expression. | 3.29e-04 | 580 | 78 | 7 | 35676659 | |
| Pubmed | Gain of Additional BIRC3 Protein Functions through 3'-UTR-Mediated Protein Complex Formation. | RPL30 COPA TBK1 DLD ABCF2 TOMM40 PRMT3 TDRD6 IQGAP3 DDX3X RPL19 | 3.29e-04 | 1425 | 78 | 11 | 30948266 |
| Pubmed | 3.81e-04 | 13 | 78 | 2 | 27713690 | ||
| Pubmed | Integrative characterization of germ cell-specific genes from mouse spermatocyte UniGene library. | 4.44e-04 | 14 | 78 | 2 | 17662146 | |
| Pubmed | 4.44e-04 | 14 | 78 | 2 | 22453919 | ||
| Pubmed | 4.70e-04 | 286 | 78 | 5 | 32041737 | ||
| Pubmed | Targeting USP10 induces degradation of oncogenic ANLN in esophageal squamous cell carcinoma. | RPL30 COPA MYO1E SGPL1 DDX60 ABCF2 TOMM40 IQGAP3 DDX3X RPL19 | 4.96e-04 | 1257 | 78 | 10 | 36526897 |
| Pubmed | 5.00e-04 | 290 | 78 | 5 | 32929329 | ||
| Pubmed | 5.12e-04 | 15 | 78 | 2 | 36963288 | ||
| Pubmed | 5.67e-04 | 168 | 78 | 4 | 39066279 | ||
| Pubmed | Genetic influences on the end-stage effector phase of arthritis. | 5.84e-04 | 16 | 78 | 2 | 11489951 | |
| Pubmed | GAD2 NAA25 ZBTB38 FBH1 COPA MYO1E TTC28 CADPS2 DDX3X AGTPBP1 | 5.88e-04 | 1285 | 78 | 10 | 35914814 | |
| Pubmed | 6.59e-04 | 469 | 78 | 6 | 37314180 | ||
| Pubmed | PDGF signaling specificity is mediated through multiple immediate early genes. | 6.61e-04 | 17 | 78 | 2 | 17143286 | |
| Pubmed | 6.77e-04 | 655 | 78 | 7 | 35819319 | ||
| Pubmed | Comparative interactome analysis of α-arrestin families in human and Drosophila. | 7.06e-04 | 313 | 78 | 5 | 38270169 | |
| Pubmed | 7.42e-04 | 18 | 78 | 2 | 19961560 | ||
| Pubmed | RECQ1 helicase is involved in replication stress survival and drug resistance in multiple myeloma. | 7.81e-04 | 183 | 78 | 4 | 28186131 | |
| Pubmed | Interactome of vertebrate GAF/ThPOK reveals its diverse functions in gene regulation and DNA repair. | 7.90e-04 | 321 | 78 | 5 | 32098917 | |
| Pubmed | 8.58e-04 | 327 | 78 | 5 | 31409639 | ||
| Pubmed | Fine mapping of collagen-induced arthritis quantitative trait loci in an advanced intercross line. | 9.19e-04 | 20 | 78 | 2 | 17082620 | |
| Pubmed | NudCL2 regulates cell migration by stabilizing both myosin-9 and LIS1 with Hsp90. | 9.31e-04 | 333 | 78 | 5 | 32665550 | |
| Pubmed | 1.00e-03 | 87 | 78 | 3 | 33711283 | ||
| Pubmed | EEF1D Promotes Glioma Proliferation, Migration, and Invasion through EMT and PI3K/Akt Pathway. | 1.01e-03 | 21 | 78 | 2 | 33029523 | |
| Pubmed | Structural snapshots of actively translating human ribosomes. | 1.01e-03 | 21 | 78 | 2 | 25957688 | |
| Pubmed | Genome-wide association study in Chinese identifies novel loci for blood pressure and hypertension. | 1.01e-03 | 21 | 78 | 2 | 25249183 | |
| Pubmed | 1.02e-03 | 510 | 78 | 6 | 16712791 | ||
| Pubmed | 1.02e-03 | 340 | 78 | 5 | 24332808 | ||
| Pubmed | KAP1 facilitates reinstatement of heterochromatin after DNA replication. | 1.03e-03 | 704 | 78 | 7 | 29955894 | |
| Pubmed | 1.05e-03 | 513 | 78 | 6 | 25798074 | ||
| Pubmed | LRRC31 inhibits DNA repair and sensitizes breast cancer brain metastasis to radiation therapy. | 1.13e-03 | 202 | 78 | 4 | 33005030 | |
| Pubmed | 1.22e-03 | 23 | 78 | 2 | 23117660 | ||
| Pubmed | Identification of 18 mouse ABC genes and characterization of the ABC superfamily in Mus musculus. | 1.22e-03 | 23 | 78 | 2 | 10708515 | |
| Pubmed | 1.28e-03 | 209 | 78 | 4 | 36779422 | ||
| Pubmed | Discovery and refinement of loci associated with lipid levels. | 1.32e-03 | 211 | 78 | 4 | 24097068 | |
| Pubmed | 1.33e-03 | 24 | 78 | 2 | 33705438 | ||
| Pubmed | CRISPR/Cas9-mediated Genomic Editing of Cluap1/IFT38 Reveals a New Role in Actin Arrangement. | 1.37e-03 | 213 | 78 | 4 | 29615496 | |
| Pubmed | Proteomic dissection of the von Hippel-Lindau (VHL) interactome. | 1.42e-03 | 98 | 78 | 3 | 21942715 | |
| Pubmed | 1.42e-03 | 215 | 78 | 4 | 30462309 | ||
| Pubmed | 1.44e-03 | 25 | 78 | 2 | 30718509 | ||
| Pubmed | 1.46e-03 | 99 | 78 | 3 | 31723608 | ||
| Pubmed | Irisin Mediates Effects on Bone and Fat via αV Integrin Receptors. | 1.48e-03 | 1451 | 78 | 10 | 30550785 | |
| Pubmed | A high-throughput approach for measuring temporal changes in the interactome. | 1.51e-03 | 1455 | 78 | 10 | 22863883 | |
| Pubmed | 1.56e-03 | 26 | 78 | 2 | 32071204 | ||
| Pubmed | Identification of 15 loci influencing height in a Korean population. | 1.68e-03 | 27 | 78 | 2 | 19893584 | |
| Pubmed | 1.68e-03 | 27 | 78 | 2 | 25133637 | ||
| Pubmed | BMP receptor 1b is required for axon guidance and cell survival in the developing retina. | 1.68e-03 | 27 | 78 | 2 | 12654290 | |
| Pubmed | Morphology-based mammalian stem cell tests reveal potential developmental toxicity of donepezil. | 1.68e-03 | 27 | 78 | 2 | 25269881 | |
| Pubmed | Systematic Analysis of Human Protein Phosphatase Interactions and Dynamics. | 1.84e-03 | 573 | 78 | 6 | 28330616 | |
| Pubmed | 1.89e-03 | 1247 | 78 | 9 | 27684187 | ||
| Pubmed | Single-cell transcriptomic landscapes of the otic neuronal lineage at multiple early embryonic ages. | 2.07e-03 | 30 | 78 | 2 | 35320729 | |
| Pubmed | Methylation of the DNA/RNA-binding protein Kin17 by METTL22 affects its association with chromatin. | 2.07e-03 | 30 | 78 | 2 | 24140279 | |
| Pubmed | 2.07e-03 | 112 | 78 | 3 | 28416769 | ||
| Pubmed | 2.20e-03 | 405 | 78 | 5 | 38187761 | ||
| Pubmed | Risk of non-Hodgkin lymphoma in association with germline variation in complement genes. | 2.21e-03 | 31 | 78 | 2 | 19344414 | |
| Pubmed | 2.21e-03 | 31 | 78 | 2 | 36159747 | ||
| Cytoband | 4q32.3 | 1.54e-03 | 34 | 78 | 2 | 4q32.3 | |
| Cytoband | 14q32.2 | 1.93e-03 | 38 | 78 | 2 | 14q32.2 | |
| GeneFamily | MOB kinase activators|STRIPAK complex | 1.96e-04 | 7 | 56 | 2 | 647 | |
| GeneFamily | Fatty acid desaturases | 2.61e-04 | 8 | 56 | 2 | 553 | |
| GeneFamily | C3 and PZP like, alpha-2-macroglobulin domain containing | 3.35e-04 | 9 | 56 | 2 | 1234 | |
| GeneFamily | X-linked mental retardation|Rho GTPase activating proteins|BAR-PH domain containing | 1.24e-03 | 17 | 56 | 2 | 1291 | |
| Coexpression | GSE17721_CTRL_VS_LPS_24H_BMDC_UP | 2.90e-05 | 199 | 78 | 6 | M3703 | |
| Coexpression | GSE9960_GRAM_NEG_VS_GRAM_NEG_AND_POS_SEPSIS_PBMC_DN | 2.90e-05 | 199 | 78 | 6 | M7131 | |
| Coexpression | GSE21546_WT_VS_SAP1A_KO_AND_ELK1_KO_DP_THYMOCYTES_DN | 2.98e-05 | 200 | 78 | 6 | M7518 | |
| ToppCell | COVID-19-Heart-CM_1|Heart / Disease (COVID-19 only), tissue and cell type | 5.25e-08 | 195 | 78 | 7 | f1ef50331eda8f1239dba6ea970df4eaccf032f1 | |
| ToppCell | RV-04._Ventricular_Cardiomyocyte_I|RV / Chamber and Cluster_Paper | 1.01e-06 | 189 | 78 | 6 | 9c1debd65c13d63fd4f3158917d621b44b714c26 | |
| ToppCell | COVID-19-Heart|COVID-19 / Disease (COVID-19 only), tissue and cell type | 1.05e-06 | 190 | 78 | 6 | 918ad5037881212008f9f69d5df5da91fd01422c | |
| ToppCell | COVID-19-Heart-CM_2|Heart / Disease (COVID-19 only), tissue and cell type | 1.22e-06 | 195 | 78 | 6 | 75fc81bddb246dca3b437fb60827b1d4fe416405 | |
| ToppCell | Parenchymal-NucSeq-Stromal-Fibroblastic-Fibro_myofibroblast|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 1.29e-06 | 197 | 78 | 6 | 6d0d68d460243a0259ada93ebda40fa7b3088eeb | |
| ToppCell | Parenchymal-NucSeq-Stromal-Fibroblastic-Fibro_adventitial|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 1.41e-06 | 200 | 78 | 6 | 74e74123ea7bf38d337a3a0248a6a51437c6ab42 | |
| ToppCell | TCGA-Bone_and_Soft_Tissue-Primary_Tumor-Sarcoma-Dedifferentiated_Liposarcoma-4|TCGA-Bone_and_Soft_Tissue / Sample_Type by Project: Shred V9 | 1.41e-05 | 175 | 78 | 5 | 16849ea8f0985108baa2085f34c3de14a4f9f28b | |
| ToppCell | COVID-19-Heart-CM_3|COVID-19 / Disease (COVID-19 only), tissue and cell type | 1.45e-05 | 176 | 78 | 5 | 9df7a124ebafb0087da0cda133a394275d7bed81 | |
| ToppCell | (3)_Chondrocytes-(32)_Chondro-prehyper-2|World / Cell class and subclass of bone marrow stroma cells in homeostatis | 1.53e-05 | 178 | 78 | 5 | c569a406c3ae183a278d8540e8eba58f4f26c5b0 | |
| ToppCell | Control-Stromal_mesenchymal-Matrix_Fibroblast-MatrixFB|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.62e-05 | 180 | 78 | 5 | 08ae0f5d95c45feba68ad99788f7af7ff4c979af | |
| ToppCell | Control-Stromal_mesenchymal-Matrix_Fibroblast|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.62e-05 | 180 | 78 | 5 | 9b1de1b4711adbf9a423f4d2d08f3f4c78f1f8f4 | |
| ToppCell | COVID-19-Heart-CM_+_EC_+_Pericyte|COVID-19 / Disease (COVID-19 only), tissue and cell type | 1.66e-05 | 181 | 78 | 5 | 719eb532453ab7cd7893726885bc75d74a10b21e | |
| ToppCell | COVID-19-Heart-CM_3|Heart / Disease (COVID-19 only), tissue and cell type | 1.70e-05 | 182 | 78 | 5 | 287fcc3897ae08841f6f85ae6c9cef16f75b1dd1 | |
| ToppCell | Control-Stromal_mesenchymal-Lung_smooth_muscle-MatrixFB_->_Myofibroblast|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.75e-05 | 183 | 78 | 5 | 7eae9b3b4d1c9b135fa7cff348393d4adec474b4 | |
| ToppCell | COVID-19-Heart-CM_1|COVID-19 / Disease (COVID-19 only), tissue and cell type | 1.80e-05 | 184 | 78 | 5 | e737f0f14c49b07bbb04a165083ac32210bc5690 | |
| ToppCell | COVID-19-Heart-CM_2|COVID-19 / Disease (COVID-19 only), tissue and cell type | 1.84e-05 | 185 | 78 | 5 | 549eeb521c3985bff396ea0f202db21822efa51f | |
| ToppCell | Control-Epithelial_alveolar-AT_2-Differentiating_AT2|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.84e-05 | 185 | 78 | 5 | 0d2add28ac1f4fa6de7699be009bf8391badaf4c | |
| ToppCell | LV-15._Ventricular_Cardiomyocyte_III|World / Chamber and Cluster_Paper | 1.84e-05 | 185 | 78 | 5 | 6baccb26f999145e51b91d94315bf8d4655bef31 | |
| ToppCell | Control-Fibroblasts-Other_FB|Control / group, cell type (main and fine annotations) | 1.94e-05 | 187 | 78 | 5 | bd3739c4a52aa1ba5deffd778e113a9800f7e158 | |
| ToppCell | RV-04._Ventricular_Cardiomyocyte_I|World / Chamber and Cluster_Paper | 1.94e-05 | 187 | 78 | 5 | 78cdcf8bc141d3b155c3c8af908431fc419c4d08 | |
| ToppCell | Control-Fibroblasts-Adventitial_FB|Control / group, cell type (main and fine annotations) | 1.99e-05 | 188 | 78 | 5 | 706a26c372add839d947749f0521a0e1f5c9b0ec | |
| ToppCell | RV-06._Ventricular_Cardiomyocyte_II|World / Chamber and Cluster_Paper | 2.04e-05 | 189 | 78 | 5 | 5e80c47f63980904c4c1ff02c201b67b456a0974 | |
| ToppCell | LV-06._Ventricular_Cardiomyocyte_II|World / Chamber and Cluster_Paper | 2.10e-05 | 190 | 78 | 5 | de5ef606a002f85c2e0e3a36c1f259d0b85a76ff | |
| ToppCell | PCW_13-14|World / Celltypes from embryonic and fetal-stage human lung | 2.10e-05 | 190 | 78 | 5 | 62a3ec1ae0829602b0569cc051210551644f1d46 | |
| ToppCell | Control-Fibroblasts|Control / group, cell type (main and fine annotations) | 2.10e-05 | 190 | 78 | 5 | 3a42a9b98d954685d38a741f44545898d0e3e9ce | |
| ToppCell | RV-06._Ventricular_Cardiomyocyte_II|RV / Chamber and Cluster_Paper | 2.10e-05 | 190 | 78 | 5 | fe8e78922c8ae928ef9a80bffd67868d5a87a091 | |
| ToppCell | Control-Stromal_mesenchymal|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.15e-05 | 191 | 78 | 5 | 14057205ddb9b4bbc582d1358d13cf36d979a61b | |
| ToppCell | LV-04._Ventricular_Cardiomyocyte_I|LV / Chamber and Cluster_Paper | 2.20e-05 | 192 | 78 | 5 | ad19e2c1d36a0566c9b12ced10db78f4781c8ea6 | |
| ToppCell | COVID-19-Heart-CM_+_EC_+_Pericyte|Heart / Disease (COVID-19 only), tissue and cell type | 2.26e-05 | 193 | 78 | 5 | dd5378a1ef8eb0eda9a3aae62f3c2f3a1402bda0 | |
| ToppCell | Adult-Mesenchymal-matrix_fibroblast_1_cell-D231|Adult / Lineage, Cell type, age group and donor | 2.26e-05 | 193 | 78 | 5 | ef2f456c094e6e3c6ee81e0668c953cb8d0e1c0a | |
| ToppCell | Children_(3_yrs)-Mesenchymal-matrix_fibroblast_2_cell|Children_(3_yrs) / Lineage, Cell type, age group and donor | 2.26e-05 | 193 | 78 | 5 | 9ab47b360bee1d4f1092c2269e58acebe9584021 | |
| ToppCell | PCW_05-06-Mesenchymal-Mesenchymal_myocytic-mes_immature_ASM1_(8)|PCW_05-06 / Celltypes from embryonic and fetal-stage human lung | 2.26e-05 | 193 | 78 | 5 | e2b455387d1de7812305200a2041a0f4759a6f54 | |
| ToppCell | Fetal_29-31_weeks-Mesenchymal-matrix_fibroblast_1_cell|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 2.32e-05 | 194 | 78 | 5 | 011e14d9ed1393275f892060e7708ffadcd0767f | |
| ToppCell | COVID-19-Fibroblasts-Alveolar_FB|COVID-19 / group, cell type (main and fine annotations) | 2.37e-05 | 195 | 78 | 5 | 603050beeb33c331d4b2e3fa46cae3f3e0e4bdc7 | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Fibroblast-kidney_interstitial_fibroblast|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 2.37e-05 | 195 | 78 | 5 | 3c3703f092b6fc1b7333426fb5e2823bfb74bb57 | |
| ToppCell | Children_(3_yrs)-Mesenchymal|Children_(3_yrs) / Lineage, Cell type, age group and donor | 2.43e-05 | 196 | 78 | 5 | bc94909f9b2dc08a59eef1914148b69720569c8f | |
| ToppCell | Control_saline-Epithelial_alveolar-AT_2-Differentiating_AT2|Control_saline / Treatment groups by lineage, cell group, cell type | 2.49e-05 | 197 | 78 | 5 | 44a59dfb889577b3160a5b13ada1276771a00241 | |
| ToppCell | Bronchial-NucSeq-Stromal-Peri/Epineurial_-NAF_epineurial|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 2.49e-05 | 197 | 78 | 5 | dfeb4a0eb4dfba90f4a3e6ba31e0ab0e4aba5849 | |
| ToppCell | tumor_Lung-Fibroblasts-COL13A1+_matrix_FBs|Fibroblasts / Location, Cell class and cell subclass | 2.49e-05 | 197 | 78 | 5 | 44f37a98f07c3e46a7e8fd3b64c2b2b44d5bbe40 | |
| ToppCell | PCW_13-14-Mesenchymal-Mesenchymal_fibroblastic-mes_immature1_(0)|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung | 2.49e-05 | 197 | 78 | 5 | 0034bae02ee7fcfea520d453ca3c842ab6963b12 | |
| ToppCell | PCW_10-12-Mesenchymal-Mesenchymal_fibroblastic|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung | 2.55e-05 | 198 | 78 | 5 | 17dc055e2a289496d9c5cdbf3297bdf906dc6d22 | |
| ToppCell | Adult-Mesenchymal|Adult / Lineage, Cell type, age group and donor | 2.55e-05 | 198 | 78 | 5 | 26e55b409db2a1637c95fae7c54b0abea1ef550c | |
| ToppCell | Fetal_29-31_weeks-Mesenchymal|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 2.55e-05 | 198 | 78 | 5 | 21cf4d81386761d09d0f6829c01c198e5524176d | |
| ToppCell | Mesenchymal|World / Lineage, Cell type, age group and donor | 2.61e-05 | 199 | 78 | 5 | 4bac110c2b3609f6ee5d0e3275da0824a6240270 | |
| ToppCell | Parenchymal-NucSeq-Stromal|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 2.68e-05 | 200 | 78 | 5 | cf433f9b43d7db07acaf70e060f8f77c974e72f3 | |
| ToppCell | Parenchymal-NucSeq-Stromal-Fibroblastic|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 2.68e-05 | 200 | 78 | 5 | 311fab076f2ceb258e3970eb21e39344b894042a | |
| ToppCell | (15)_Treg|World / shred on Cell_type and subtype | 3.16e-05 | 207 | 78 | 5 | 83bae0389269077434d1e5ab53205ae569ff4479 | |
| ToppCell | Control-Stromal_mesenchymal-Matrix_Fibroblast-Activated_MatrixFB|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 6.91e-05 | 125 | 78 | 4 | b162a5bfbb8ac5e65e13578fef9de442a9e4fd8b | |
| ToppCell | Control-Plasmablast|World / disease group and sub_cluster of B and Plasma cells(res = 0.5) | 1.23e-04 | 145 | 78 | 4 | fe68582f5a15b9714cb84fa32ac880e13cb69895 | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Fibroblast-kidney_interstitial_fibroblast-proliferative_fibroblast|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.23e-04 | 145 | 78 | 4 | 051d964ff6bdc12ba3f0459d3e6ab16fa9507b0b | |
| ToppCell | 367C-Lymphocytic-CD4_T-cell-Treg_cell_4|Lymphocytic / Donor, Lineage, Cell class and subclass (all cells) | 1.47e-04 | 152 | 78 | 4 | 6d02b50e9e9ecf820f84a79e46d153a4840a1cfe | |
| ToppCell | metastatic_Brain-Fibroblasts-Smooth_muscle_cells|Fibroblasts / Location, Cell class and cell subclass | 1.55e-04 | 154 | 78 | 4 | 423f58fc7dcef068458cbf7b4ee989e37227041e | |
| ToppCell | Children_(3_yrs)-Mesenchymal-chondrocyte|Children_(3_yrs) / Lineage, Cell type, age group and donor | 1.67e-04 | 157 | 78 | 4 | f147e24f2ece82e1c54750868954d09b3c461804 | |
| ToppCell | Healthy/Control-Treg|Healthy/Control / Disease group and Cell class | 1.75e-04 | 159 | 78 | 4 | 16a322760c99f3e2c3b73cbb399f77868951d3cb | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Fibroblast-Collagen-high_Fibroblast-|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 1.75e-04 | 159 | 78 | 4 | e812cbde59188924c6277c3feadf1a9592fa62a4 | |
| ToppCell | Adult-Mesenchymal-chondrocyte|Adult / Lineage, Cell type, age group and donor | 1.75e-04 | 159 | 78 | 4 | 3f7305ee76447064b5c846c4f576360a2f7e0b7c | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Fibroblast-Collagen-high_Fibroblast|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 1.75e-04 | 159 | 78 | 4 | 2607b562903228274fbd96168ba826782fab0b53 | |
| ToppCell | PND14-Mesenchymal-Mesenchymal_myocytic-Myofibroblast_airway-ASMC|PND14 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.79e-04 | 160 | 78 | 4 | 8624f101828efd32cdd38a65df8d94d690720a63 | |
| ToppCell | PND14-Mesenchymal-Mesenchymal_myocytic-Myofibroblast_airway-ASMC-ASMC_mature|PND14 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.79e-04 | 160 | 78 | 4 | 9de3dd6b9d4b51314d60b3b01f4132bcfa2dfc18 | |
| ToppCell | Healthy/Control-Treg|World / Disease group and Cell class | 1.83e-04 | 161 | 78 | 4 | 457297cda5c9cee3bcc069fdecbbe24def027e5f | |
| ToppCell | normal_Lung-Myeloid_cells-Undetermined|Myeloid_cells / Location, Cell class and cell subclass | 1.83e-04 | 161 | 78 | 4 | 283012858e575c70d09950de53da041509f59bfa | |
| ToppCell | droplet-Marrow-nan-21m-Hematologic-erythroid_progenitor|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.88e-04 | 162 | 78 | 4 | d0ffebf5adee8a3ac9b81a4b793184f54010489a | |
| ToppCell | Fetal_brain-organoid_Tanaka_cellReport-GW26-Neuronal-Interneuron|GW26 / Sample Type, Dataset, Time_group, and Cell type. | 1.94e-04 | 64 | 78 | 3 | fefabdf8d72a8f3caf78eb79d759edb475bdb2ad | |
| ToppCell | Primary_Motor_Cortex_(M1)-Neuronal-Glutamatergic_Excit-Glut_B_(ET)-Glut_ET_L5_FEZF2-Exc_L3-5_FEZF2_DCN|Primary_Motor_Cortex_(M1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 2.01e-04 | 165 | 78 | 4 | aad0ab96d9d4387edfcef2b114346a030eb4b021 | |
| ToppCell | Mid-temporal_gyrus_(MTG)-Neuronal-Glutamatergic_Excit-Glut_B_(ET)|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 2.16e-04 | 168 | 78 | 4 | 8e9046b661642293eee640ead91d43db9d8daae0 | |
| ToppCell | TCGA-Colorectal-Solid_Tissue_Normal-Rectum_normal_tissue-Rectum_normal_tissue-6|TCGA-Colorectal / Sample_Type by Project: Shred V9 | 2.16e-04 | 168 | 78 | 4 | 5ce3129a023a48a3d7e6b9306c1fc5addfef9675 | |
| ToppCell | Mid-temporal_gyrus_(MTG)-Neuronal-Glutamatergic_Excit-Glut_B_(ET)-Glut_ET_L5_FEZF2|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 2.16e-04 | 168 | 78 | 4 | c7d66e5d9311ceaab3f144f1516b49b8812976b8 | |
| ToppCell | Primary_Motor_Cortex_(M1)-Neuronal-Glutamatergic_Excit-Glut_B_(ET)-Glut_ET_L5_FEZF2|Primary_Motor_Cortex_(M1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 2.21e-04 | 169 | 78 | 4 | d0c64ca31053dfc283a07d5ad1117ca7dc1777a7 | |
| ToppCell | Primary_Motor_Cortex_(M1)-Neuronal-Glutamatergic_Excit-Glut_B_(ET)|Primary_Motor_Cortex_(M1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 2.21e-04 | 169 | 78 | 4 | d79abfbeffd082a4fbffbc1051ffc474374874fa | |
| ToppCell | renal_medulla_nuclei-CKD+DKD_normotensive-Mesenchymal-Fibroblast-Collagen+matrisome-high_fibroblast|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 2.26e-04 | 170 | 78 | 4 | fa753cc8fbd04e63c9a303da4dc17ee2ce907f92 | |
| ToppCell | COVID-19-Heart-CM_+_Macrophage|COVID-19 / Disease (COVID-19 only), tissue and cell type | 2.26e-04 | 170 | 78 | 4 | 3f15242a1d3e4e9871d9170b2ef05842fb609c29 | |
| ToppCell | COVID-19-Heart-CM_+_Macrophage|Heart / Disease (COVID-19 only), tissue and cell type | 2.26e-04 | 170 | 78 | 4 | 4232fe937909f93d3736988c707b8f95ce993398 | |
| ToppCell | Primary_Motor_Cortex_(M1)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_PVALB_1-Inh_L6_LHX6_GLP1R|Primary_Motor_Cortex_(M1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 2.26e-04 | 170 | 78 | 4 | 40675b55269ffa57fb7fcdb903c81b02b4e01f8f | |
| ToppCell | renal_medulla_nuclei-CKD+DKD_normotensive-Mesenchymal-Fibroblast-Collagen+matrisome-high_fibroblast-|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 2.26e-04 | 170 | 78 | 4 | 03044e1436443b28dd39d5ef4fdb25c18e3a7546 | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference-Mesenchymal-Fibroblast-kidney_interstitial_fibroblast|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 2.31e-04 | 171 | 78 | 4 | 5d31fc9b60329d4ae3c77e4ca679359d9314397d | |
| ToppCell | PND10-Mesenchymal-Mesenchymal_myocytic-Myofibroblast_airway-ASMC|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 2.31e-04 | 171 | 78 | 4 | 82de2885c8ce4fb7776da6a0207b3355c0910121 | |
| ToppCell | PND10-Mesenchymal-Mesenchymal_myocytic-Myofibroblast_airway-ASMC-ASMC_mature|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 2.31e-04 | 171 | 78 | 4 | 09e653973962fb884878089d281f0947f7a285f6 | |
| ToppCell | -Donor_08|World / lung cells shred on cell class, cell subclass, sample id | 2.41e-04 | 173 | 78 | 4 | 88be9182fbb1bc83531cd41e59ea57c112a21d54 | |
| ToppCell | TCGA-Breast-Solid_Tissue_Normal-Breast_normal_tissue-Breast_normal_tissue-3|TCGA-Breast / Sample_Type by Project: Shred V9 | 2.47e-04 | 174 | 78 | 4 | 7f8f5fafae08676d2b90cab9802c3c9320f1370e | |
| ToppCell | TCGA-Breast-Solid_Tissue_Normal|TCGA-Breast / Sample_Type by Project: Shred V9 | 2.47e-04 | 174 | 78 | 4 | e2f240d60bffbe8e6d60f0bb405b231bd3c96875 | |
| ToppCell | TCGA-Breast-Solid_Tissue_Normal-Breast_normal_tissue-Breast_normal_tissue|TCGA-Breast / Sample_Type by Project: Shred V9 | 2.47e-04 | 174 | 78 | 4 | 0f3ec0d0d4344e10c9b48adc9174123f6402dc51 | |
| ToppCell | TCGA-Breast-Solid_Tissue_Normal-Breast_normal_tissue|TCGA-Breast / Sample_Type by Project: Shred V9 | 2.47e-04 | 174 | 78 | 4 | 1aadbf2642b6d1320ceabd92e6ff59e11f16c315 | |
| ToppCell | Primary_Motor_Cortex_(M1)-Neuronal-Inh_GABAergic-i_Gaba_1-GABA_L1_LAMP5-Inh_L6_LAMP5_C1QL2|Primary_Motor_Cortex_(M1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 2.52e-04 | 175 | 78 | 4 | 4d42a97c450e919a409477a7db85e2668f0d473b | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Fibroblast-kidney_interstitial_fibroblast-Adaptive_/_Maladaptive_/_Repairing_Fibroblast|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 2.52e-04 | 175 | 78 | 4 | 795a6564d5a75ffd35d39f5274b9e8d28708bbc8 | |
| ToppCell | tumor_Lymph_Node_/_Brain-Fibroblasts-COL13A1+_matrix_FBs|tumor_Lymph_Node_/_Brain / Location, Cell class and cell subclass | 2.58e-04 | 176 | 78 | 4 | 510f9a14dc1c151d24d079e0cc004cdf4f86336c | |
| ToppCell | PND10-Mesenchymal-Mesenchymal_structural-Fibroblastic-AF2-AF2_G2M|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 2.63e-04 | 177 | 78 | 4 | 3e149bff1f1b393a7abe98984e37981c8296f95d | |
| ToppCell | droplet-Heart-nan-3m-Mesenchymal-smooth_muscle_cell|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.63e-04 | 177 | 78 | 4 | dbdbdc8ed9ef0b529694242ef9f9f07a42e16005 | |
| ToppCell | 3'-GW_trimst-1.5-SmallIntestine-Epithelial-neuro-epithelial-K_cells_(GIP+)|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 2.63e-04 | 177 | 78 | 4 | 43dce527392f3b8364bb6a55268ce9d6518d3a29 | |
| ToppCell | droplet-Heart-nan-3m-Mesenchymal-smooth_muscle_cell|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.69e-04 | 178 | 78 | 4 | 416f85e51f45ec7949451fd47611a84e33e87245 | |
| ToppCell | facs-Heart-LV-3m-Mesenchymal-smooth_muscle_cell|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.75e-04 | 179 | 78 | 4 | 8da6863edc756540bb097cc7221c1408640d9bb4 | |
| ToppCell | -Donor_02|World / lung cells shred on cell class, cell subclass, sample id | 2.75e-04 | 179 | 78 | 4 | 10fadbaa1b6d21cbf9f354d717cc4c225619f4fd | |
| ToppCell | facs-Heart-LV-3m-Mesenchymal-smooth_muscle_cell|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.75e-04 | 179 | 78 | 4 | f39c13c99a07d009cc677e363ffe089089c64916 | |
| ToppCell | 390C-Lymphocytic-ILC-ILC-1|Lymphocytic / Donor, Lineage, Cell class and subclass (all cells) | 2.75e-04 | 179 | 78 | 4 | 3edcd1356e49b1f5514c585861999e079ca5e579 | |
| ToppCell | LPS-IL1RA-Stromal_mesenchymal-Lung_smooth_muscle-MatrixFB_->_Myofibroblast|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.75e-04 | 179 | 78 | 4 | 02c90d8306016365ed811f0c63cfb3ac7b85464c | |
| ToppCell | LV|World / Chamber and Cluster_Paper | 2.81e-04 | 180 | 78 | 4 | 5ac6f485a58bb29462fec02dfbe8eb70864eafe3 | |
| ToppCell | Mid-temporal_gyrus_(MTG)-Neuronal-Glutamatergic_Excit-Glut_C-D_(RORB)-Glut_D_(IT_RORB_THEMIS_LINC00507)_5-Exc_L4-5_RORB_HNRNPA1P46|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 2.81e-04 | 180 | 78 | 4 | 8923a42a6db9c6e9f3ce2ca9530e620dfea700ba | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-DN4_thymocyte|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.81e-04 | 180 | 78 | 4 | be10fe5bf7c3a671c42704ce7dd8226ab6896794 | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-DN4_thymocyte|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.81e-04 | 180 | 78 | 4 | 3b747a517ce75ef2ff09011c037dad7b01ed3e03 | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Epithelial-Collecting_tubule_epithelial_cell-kidney_connecting_tubule_epithelial_cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 2.81e-04 | 180 | 78 | 4 | 788d5fbf688365b5d92d3aa19b9f8e9448f8be5a | |
| ToppCell | Thalamus-Macroglia|Thalamus / BrainAtlas - Mouse McCarroll V32 | 2.87e-04 | 181 | 78 | 4 | 4f62b63854a4e9fea6e839f0340e78392c66fb0e | |
| Drug | Clemizole hydrochloride [1163-36-6]; Down 200; 11uM; PC3; HT_HG-U133A | 4.48e-06 | 193 | 78 | 7 | 3672_DN | |
| Drug | nifedipine; Down 200; 10uM; MCF7; HG-U133A | 5.48e-06 | 199 | 78 | 7 | 603_DN | |
| Disease | hypertension | 1.33e-04 | 307 | 75 | 6 | EFO_0000537 | |
| Disease | urate measurement, bone density | 1.76e-04 | 619 | 75 | 8 | EFO_0003923, EFO_0004531 | |
| Disease | cerebral palsy (implicated_via_orthology) | 2.83e-04 | 10 | 75 | 2 | DOID:1969 (implicated_via_orthology) | |
| Disease | neurodegenerative disease (implicated_via_orthology) | 5.19e-04 | 145 | 75 | 4 | DOID:1289 (implicated_via_orthology) | |
| Disease | level of Phosphatidylethanolamine (18:0_20:4) in blood serum | 1.06e-03 | 19 | 75 | 2 | OBA_2045140 | |
| Disease | p-tau:beta-amyloid 1-42 ratio measurement | 1.06e-03 | 19 | 75 | 2 | EFO_0007709 | |
| Disease | lipoprotein measurement | 2.45e-03 | 105 | 75 | 3 | EFO_0004732 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| MFLAAIAHHYTFSYK | 301 | Q9NVA4 | |
| TYYSSLGDYMKNIHK | 291 | Q96P64 | |
| KIAHGHYKQSSSYSF | 431 | P04003 | |
| IHMHNKKLKYYTGNY | 296 | Q9UG63 | |
| HRFYMHHSFTKFNKN | 66 | O60583 | |
| YKFCGRTHMYKHAQH | 1466 | Q86V15 | |
| QKELMYKHSNGSYSA | 1011 | A8K2U0 | |
| YIGSHSHRMKAVDFY | 786 | Q4L235 | |
| EAKMHATGYVHATFY | 476 | P19801 | |
| YHGHSRKKNVFMYGC | 1016 | Q9UPW5 | |
| MYTSYNKHISLHKAF | 711 | Q96BY7 | |
| TYYSSLGDYMKNIHK | 291 | Q5VW22 | |
| RGYAFVMYCHKHEAK | 111 | A0AV96 | |
| YYFAAVAHLHMGKQA | 246 | Q9H3S7 | |
| QDHTFKSELGHYMYV | 206 | Q7Z304 | |
| MGAEAHVNTCYKHFY | 176 | Q86TA1 | |
| FFYHMYGKHIGSLNL | 836 | Q8NFP4 | |
| LENMAYEHHYKGSSR | 571 | O00571 | |
| KYMSFTSGDKSAHGY | 151 | O75914 | |
| MHASYLFQQDKHYDL | 421 | Q05329 | |
| MDLFCYGSHYFHKVA | 296 | A8MVJ9 | |
| QDFNKMKGAAHYHSL | 336 | Q86VF7 | |
| YHKSEFYNKGMLSAH | 341 | Q8NBH2 | |
| QMYYSGSLEAKSTHH | 186 | Q8NCR3 | |
| MSLNAYALDFYKHGS | 1636 | Q8IY21 | |
| AQRGIGYHHSSMYFK | 1241 | Q5H9U9 | |
| GYHHSSMYFKEKEFV | 1246 | Q5H9U9 | |
| ILYMHFSHSYSGLAK | 501 | Q9HCI6 | |
| HGHMGYVFSKTYNVT | 796 | Q14432 | |
| IYSFHGKVEKYMCFH | 156 | Q9Y2T6 | |
| VQHDMKDGTAYYFHL | 671 | Q86VI3 | |
| FHSMAYGHIGRKYQS | 511 | Q8NFZ0 | |
| QMEDYHYAHLIKTFG | 941 | Q14185 | |
| DSMVHKHGLEFYGYI | 76 | O60678 | |
| FSSYGHYGIHEEMLK | 221 | O60678 | |
| YAVHGNMLHYVKDRF | 326 | P53621 | |
| HHMTKAFLFYGTDFN | 116 | Q6P4F1 | |
| KMNYYDHADFHHSVK | 376 | Q8TAL5 | |
| SYKHKGALHNYKMTD | 1316 | P01031 | |
| YMGLEFKKHHDYYIT | 121 | P98172 | |
| AEHYMFLKGHETYSY | 231 | O15121 | |
| AEHYMFLKGHETYSY | 231 | Q6QHC5 | |
| AHMKHSGYLYALGQK | 486 | Q86UW7 | |
| LLNNSHYYHMAHGKD | 91 | P09622 | |
| HYYHMAHGKDFASRG | 96 | P09622 | |
| MGAEAHVNTCYKHFY | 176 | Q70IA8 | |
| MHTYGIIYTGYATKH | 56 | Q8TC84 | |
| NNHFSTMTKYKGQLY | 446 | Q8NBR6 | |
| SGDHSDHMHYYQGKK | 746 | P78332 | |
| HYYHSEAFKGQMEKS | 321 | Q2M3C7 | |
| DTSYGYKDFSRHGMH | 331 | Q9Y6P5 | |
| YPTMKDFNHSYHACG | 46 | O95807 | |
| QLHSYFYSTHDMKIG | 971 | O60522 | |
| FAHCASVYKHHYMDG | 501 | Q8IXI1 | |
| LNMNGYFHEAYFKKH | 506 | Q8WZA1 | |
| DRHMYHSLYLKVKGN | 116 | P84098 | |
| LDKMHYSIEGKDTHY | 2606 | Q9NT68 | |
| HQSQDKKIHVYGYSM | 81 | Q9NRX4 | |
| SKYKLYRHMATHSAQ | 81 | Q9UPG8 | |
| DMRHHGSFNYLKFFK | 31 | A0A1B0GWK0 | |
| AHAAFNKAASYFGMK | 241 | O95470 | |
| GMYYCKAQEHTFIHT | 661 | O95025 | |
| NTYSYHLKFLLGHGM | 131 | O94911 | |
| KGSDSHIYNVHYTMS | 66 | O75829 | |
| EHMYTHKGKSYRYNR | 366 | P24278 | |
| IHVKQAGQHSYYSAM | 281 | Q8NEY3 | |
| FLDFNHFYGMQKYHH | 141 | Q63HM9 | |
| YHKFMAFKSFADLQH | 1176 | Q9UKE5 | |
| FMQYGDHLYSKGNHD | 391 | Q9H270 | |
| FKMYGYLTQHQKIHT | 591 | Q86YE8 | |
| EYYAMLAKTGVHHYS | 61 | P62888 | |
| SDKHGFTILNSMHKY | 216 | Q13207 | |
| DHKYKMNLYGFHGGQ | 3121 | P22105 | |
| YHYSKTQHSKAEHMQ | 836 | Q8IWV7 | |
| KLYGYQAQHYVCMKH | 186 | Q99727 | |
| GQAGMHATYYHKASD | 266 | O96008 | |
| AHGHLAAVYMALGKY | 796 | Q96AY4 | |
| HYNMFNHHFFDGKTA | 241 | Q9H5U6 | |
| MTYYILKNHQKSFHA | 526 | Q8NAP3 | |
| QTVQKEYTYSKHGMH | 261 | A8MT65 | |
| DKQKLYYHATKAMTH | 586 | Q9UHD2 | |
| GFIIHHYAGKVSYDM | 501 | Q12965 | |
| HSHLFMAYARVGEYK | 116 | Q14CX7 |